Yvonne Saenger is an Oncology physician affiliated with Albert Einstein College of Medicine. OpenAlex indexes 317 publications with 4,493 citations (h-index 31); ClinicalTrials.gov lists 1 registered study matched to this name.
Overview
Scholarship
indexed output and impact (OpenAlex)Distinct works indexed by OpenAlex, matched via ORCID.
Total citations across indexed works.
Hirsch index, productivity × impact (OpenAlex).
Clinical & industry
trials, payments and federal fundingContact
The practice address and phone this provider lists in the federal NPPES (CMS) registry.
Practice address
622 W 168th St
New York, NY 100323720
Telephone
212-305-5098Registry record last updated 4 Nov 2016.
Clinical trials
- MRI and PET to Assess Pembrolizumab Response
Sponsor: Columbia University
Registered studies on ClinicalTrials.gov where the overall official or a site investigator name-matches this physician, confirmed against known institution/geography. Latest few shown; the full list is part of the full profile.
Industry payments
5 companies reported payments to CMS in program years 2021 onward. These are public disclosures, not judgments. The latest:
- Regeneron Pharmaceuticals, Inc.Program year20251 payment
- AstraZeneca Pharmaceuticals LPProgram year20251 payment
- Novartis Pharmaceuticals CorporationProgram year20252 payments
Payment records matched to this physician's NPI in CMS Open Payments, program years 2021 onward.
Medicare prescribing footprint (2024)
The drugs this prescriber writes for Medicare patients, grouped by drug class and therapeutic area. Every percentage is a share of their total prescribing, so you can see what they prescribe most. These are proportions, not patient counts or dollar amounts. No condition is inferred: the claims record what was prescribed, never why.
Cancer & immunology
40.8%Hedgehog Pathway Inhibitor40.8%Erivedge100%Part D<11 patientsBlood & clotting
32.7%Factor Xa inhibitor32.7%Eliquis100%Part D<11 patientsNervous system
26.5%Opioid Agonist26.5%Oxycodone Hcl100%Part D<11 patients
Drug classes come from the WHO ATC and U.S. National Library of Medicine (RxClass) classifications; prescribing counts come from the CMS Medicare Part D Prescribers file. Each drug is counted once, under its primary class. Medicare fee-for-service only, so no Medicare Advantage, commercial, or pediatric prescribing is included. CMS publishes this data about 17 months after the fact.
NIH funding
5 NIH research awards on record, funded 2018–2026 per NIH RePORTER. The latest:
- Montefiore Einstein Clinical Oncology Training Program in the Bronx
Albert Einstein College of Medicine
FY2026$707,977K12CA279871 - Applying pathomics to establish a biosignature for aggressive skin melanoma
Albert Einstein College of Medicine
FY2026$600,844R01CA260375 - Montefiore Einstein Clinical Oncology Training Program in the Bronx
Albert Einstein College of Medicine
FY2025$691,824K12CA279871
Awards in the NIH RePORTER records where a principal investigator name matches this physician at an organization in their practice state. Latest award years shown; each row links to the project record on RePORTER.
Publications
Matched to this physician's OpenAlex author record; most-cited works shown first.
- Landscape of mutations in early stage primary cutaneous melanoma: An <scp>InterMEL</scp> study
Pigment Cell & Melanoma Research
2022
Similar KOLs
Other experts from the same institution or the same specialty.
Richard Lipton, MD
Albert Einstein College of Medicine
Marina Konopleva, MD, PhD
Albert Einstein College of Medicine
Solomon Moshe, MD
Albert Einstein College of Medicine
Shlomo Shinnar, MD, PhD
Albert Einstein College of Medicine
A basic profile from our physician directory: identity and practice contact from the federal NPPES registry, research from OpenAlex, trials from ClinicalTrials.gov, payments from CMS Open Payments — shown itemized where we have matched records, as a count where we only have a total. This person hasn't been through our full identity-adjudication pipeline yet, so funding, congress activity and public presence aren't shown. Absence of a section means “not yet looked,” never “none found.”